Austrian Left Atrial Appendage Closure Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Graz
About this trial
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who received LAAC in Austria
Disqualifiers
Absence of informed consent
Trial population
Patients with atrial fibrillation, who received LAAC in Austria.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
LAAC
DeviceLeft atrial appendage closure
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Number of participants with successful left atrial appendage closure, as defined by European Society of Cardiology Guidelines
Time frame
30 daysSecondary outcomes
1
Number of participants with death, stroke or bleeding
Time frame
5 years2
Number of participants with procedure-related adverse events
Time frame
30 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov